Yearly flu shot alternative? new drug CD388 tested for Long-Term safety
NCT ID NCT07225959
First seen Nov 10, 2025 · Last updated May 24, 2026 · Updated 19 times
Summary
This study tests whether giving repeated annual doses of an experimental drug called CD388 is safe for healthy adults. About 400 people who already tolerated one dose will receive two more doses over two years. Researchers will monitor for side effects and check if the body makes antibodies against the drug, which could affect how well it works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Floridian Clinical Research
Miami Lakes, Florida, 33016, United States
-
Spartanburg Medical Research
Spartanburg, South Carolina, 29303, United States
-
hVIVO Serviced Limited
London, England, E1 1EQ, United Kingdom
Conditions
Explore the condition pages connected to this study.